SE0401578D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- SE0401578D0 SE0401578D0 SE0401578A SE0401578A SE0401578D0 SE 0401578 D0 SE0401578 D0 SE 0401578D0 SE 0401578 A SE0401578 A SE 0401578A SE 0401578 A SE0401578 A SE 0401578A SE 0401578 D0 SE0401578 D0 SE 0401578D0
- Authority
- SE
- Sweden
- Prior art keywords
- hydrogen
- methyl
- fluoro
- chloro
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0401578A SE0401578D0 (sv) | 2004-06-18 | 2004-06-18 | Novel compounds |
US11/152,777 US7553849B2 (en) | 2004-06-18 | 2005-06-15 | Compounds |
ZA200609265A ZA200609265B (en) | 2004-06-18 | 2005-06-15 | Thienopyridone carboxamides and their medical use |
AT05753986T ATE375353T1 (de) | 2004-06-18 | 2005-06-15 | Thienopyridoncarbonsäureamide und deren medizinische verwendung |
DE602005002847T DE602005002847T2 (de) | 2004-06-18 | 2005-06-15 | Thienopyridoncarbonsäureamide und deren medizinische verwendung |
EP05753986A EP1776369B1 (fr) | 2004-06-18 | 2005-06-15 | Carboxamides de thiénopyridone et leur utilisation médicale |
ES05753986T ES2294721T3 (es) | 2004-06-18 | 2005-06-15 | Tienopiricarboxamidas y su utilizacion medica. |
PCT/EP2005/052767 WO2005123744A1 (fr) | 2004-06-18 | 2005-06-15 | Carboxamides de thiénopyridone et leur utilisation médicale |
RU2007101702/04A RU2374250C2 (ru) | 2004-06-18 | 2005-06-15 | Тиенопиридон карбоксамиды и их применение в медицине |
AU2005254731A AU2005254731B2 (en) | 2004-06-18 | 2005-06-15 | Thienopyridone carboxamides and their medical use |
CA2570506A CA2570506C (fr) | 2004-06-18 | 2005-06-15 | Carboxamides de thienopyridone et leur utilisation medicale |
CN2005800199955A CN1980937B (zh) | 2004-06-18 | 2005-06-15 | 噻吩并吡啶酮甲酰胺及其医药用途 |
JP2007515955A JP4906718B2 (ja) | 2004-06-18 | 2005-06-15 | チエノピリドンカルボキサミド及びその医学的使用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0401578A SE0401578D0 (sv) | 2004-06-18 | 2004-06-18 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0401578D0 true SE0401578D0 (sv) | 2004-06-18 |
Family
ID=32906817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0401578A SE0401578D0 (sv) | 2004-06-18 | 2004-06-18 | Novel compounds |
Country Status (13)
Country | Link |
---|---|
US (1) | US7553849B2 (fr) |
EP (1) | EP1776369B1 (fr) |
JP (1) | JP4906718B2 (fr) |
CN (1) | CN1980937B (fr) |
AT (1) | ATE375353T1 (fr) |
AU (1) | AU2005254731B2 (fr) |
CA (1) | CA2570506C (fr) |
DE (1) | DE602005002847T2 (fr) |
ES (1) | ES2294721T3 (fr) |
RU (1) | RU2374250C2 (fr) |
SE (1) | SE0401578D0 (fr) |
WO (1) | WO2005123744A1 (fr) |
ZA (1) | ZA200609265B (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112013007850A2 (pt) * | 2010-10-14 | 2016-06-07 | Immunahr Ab | 1,2-diidro-4-hidróxi-2-oxo-quinolina-3-carboxanilidas como ativadores de ahr |
CN102127091B (zh) * | 2010-12-30 | 2012-11-21 | 天津药物研究院 | 含有杂环的希夫碱化合物 |
EP3904357A4 (fr) * | 2018-11-20 | 2022-08-03 | The National Institutes of Pharmaceutical R&D Co., Ltd | Composé spyro et ses applications médicales |
CN114957278B (zh) * | 2021-02-20 | 2023-08-11 | 兰州大学 | 胰高血糖素受体拮抗剂及其用途 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5219864A (en) * | 1991-03-12 | 1993-06-15 | Kyowa Hakko Kogyo Co., Ltd. | Thienopyridine derivatives |
DE4227747A1 (de) * | 1992-08-21 | 1994-02-24 | Basf Ag | Heteroaromatisch kondensierte Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung |
GB9311562D0 (en) * | 1993-06-04 | 1993-07-21 | Fujisawa Pharmaceutical Co | Heterocyclic derivatives |
SE9801474D0 (sv) * | 1998-04-27 | 1998-04-27 | Active Biotech Ab | Quinoline Derivatives |
SE9802549D0 (sv) * | 1998-07-15 | 1998-07-15 | Active Biotech Ab | Quinoline derivatives |
SE9802550D0 (sv) * | 1998-07-15 | 1998-07-15 | Active Biotech Ab | Quinoline derivatives |
DK1159279T3 (da) | 1999-03-09 | 2003-02-17 | Upjohn Co | 4-Oxo-4,7-dihydro-thieno[2,3-b]pyridin-5-carboxamider som antivirale midler |
SE0002320D0 (sv) * | 1999-10-25 | 2000-06-21 | Active Biotech Ab | Malignant tumors |
PT1419772E (pt) | 2001-08-24 | 2007-09-05 | Dynogen Pharmaceuticals Inc | Agente preventivo/agente terapêutico papa ibs com predominância de obstipação. |
AR038294A1 (es) | 2002-01-14 | 2005-01-12 | Upjohn Co | Oxotieno(3,2-b)piridincarboxamidas como agentes antivirales |
WO2004019939A1 (fr) | 2002-08-30 | 2004-03-11 | Pharmacia & Upjohn Company | Methode de prevention ou de traitement de l'atherosclerose ou de la restenose |
-
2004
- 2004-06-18 SE SE0401578A patent/SE0401578D0/xx unknown
-
2005
- 2005-06-15 AT AT05753986T patent/ATE375353T1/de not_active IP Right Cessation
- 2005-06-15 AU AU2005254731A patent/AU2005254731B2/en not_active Ceased
- 2005-06-15 CA CA2570506A patent/CA2570506C/fr not_active Expired - Fee Related
- 2005-06-15 ES ES05753986T patent/ES2294721T3/es active Active
- 2005-06-15 WO PCT/EP2005/052767 patent/WO2005123744A1/fr active IP Right Grant
- 2005-06-15 EP EP05753986A patent/EP1776369B1/fr not_active Not-in-force
- 2005-06-15 DE DE602005002847T patent/DE602005002847T2/de active Active
- 2005-06-15 US US11/152,777 patent/US7553849B2/en not_active Expired - Fee Related
- 2005-06-15 RU RU2007101702/04A patent/RU2374250C2/ru not_active IP Right Cessation
- 2005-06-15 ZA ZA200609265A patent/ZA200609265B/en unknown
- 2005-06-15 CN CN2005800199955A patent/CN1980937B/zh not_active Expired - Fee Related
- 2005-06-15 JP JP2007515955A patent/JP4906718B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US7553849B2 (en) | 2009-06-30 |
US20060004038A1 (en) | 2006-01-05 |
DE602005002847T2 (de) | 2008-07-10 |
JP2008502655A (ja) | 2008-01-31 |
CN1980937A (zh) | 2007-06-13 |
RU2007101702A (ru) | 2008-07-27 |
JP4906718B2 (ja) | 2012-03-28 |
AU2005254731A1 (en) | 2005-12-29 |
EP1776369B1 (fr) | 2007-10-10 |
ES2294721T3 (es) | 2008-04-01 |
ZA200609265B (en) | 2008-05-28 |
RU2374250C2 (ru) | 2009-11-27 |
WO2005123744A1 (fr) | 2005-12-29 |
AU2005254731B2 (en) | 2010-10-21 |
CA2570506C (fr) | 2012-12-18 |
CN1980937B (zh) | 2011-08-10 |
DE602005002847D1 (de) | 2007-11-22 |
ATE375353T1 (de) | 2007-10-15 |
CA2570506A1 (fr) | 2005-12-29 |
EP1776369A1 (fr) | 2007-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ME01421B (me) | 5-supstituisani derivati kinazolinona kao protivtumorska sredstva | |
HRP20090162T1 (en) | Quinolinone-carboxamide compounds as 5-ht4 receptor agonists | |
YU1501A (sh) | Derivati hinolina | |
NO20071921L (no) | Fremgangsmater for behandling av epileptogenese og epilepsi | |
SE9801474D0 (sv) | Quinoline Derivatives | |
ECSP088179A (es) | Compuestos de carbamato para usarse en el tratamiento de desordenes neurodegenerativos | |
RS53075B (en) | 1,2,4-TRIAZOLO [4,3-A] PYRIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OR PREVENTION OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS | |
NO20080877L (no) | Fremgangsmater for behandling av substansrelaterte forstyrrelser | |
TW200744575A (en) | Methods of treating epileptogenesis | |
CY1110145T1 (el) | Αλκυλο-υποκατεστημενες ινδολοκινοξαλινες | |
MY138156A (en) | Carbamate compounds for use in preventing or treating neurodegenerative disorders | |
MY157373A (en) | Carbamate compounds for use in preventing or treating movement disorders | |
DE602005002847D1 (de) | Thienopyridoncarbonsäureamide und deren medizinische verwendung | |
DK1408953T3 (da) | Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bipolær sygdom | |
EA200700871A1 (ru) | Способы нейропротекции | |
MY136391A (en) | Carbamate compounds for use in preventing or treating anxiety disorders | |
RS67503A (en) | Carbamate compounds for use in preventing of treating psychotic disorders | |
EA200700322A1 (ru) | Оксазолидиноны, содержащие оксиндолы, в качестве антибактериальных агентов | |
PL422539A1 (pl) | Związki N-arylosulfonyloindolowe do leczenia chorób OUN | |
MY136733A (en) | Carbamate compounds for use in preventing or treating psychotic disorders | |
TH70879A (th) | อนุพันธ์ของ 5-(ไพริดิน-3-อิล)-1-แอซาไบไซโคล[3.2.1]ออกเทน, การเตรียมสาร และการประยุกต์ใช้สารในการบำบัดรักษา |